Optimize Your Portfolio, Today

Experience frustration-free portfolio strategy

Harness the power of AI for drug development to transform decision-making and optimize your pipeline. Intelligencia AI equips pharmaceutical companies with data-driven tools to enhance efficiency, reduce costs, and improve outcomes. 

Optimize PTRS With AI

Leverage advanced analytics to calibrate the probability of technical and regulatory success (PTRS) for better decision-making.

Predict Drug Success With AI

Use machine learning to evaluate phase transition  probabilities across development stages.

Drive Objective Based Decisions

Reduce subjectivity and bias with AI-powered, data-backed insights.

Revolutionizing Drug Development With AI

Harness the power of AI for drug development to transform decision-making and optimize your pipeline. Intelligencia AI equips pharmaceutical companies with data-driven tools to enhance efficiency, reduce costs, and improve outcomes. 

Let's Talk

Fill out the form to schedule a demonstration of Intelligencia AI
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Predicting Drug Success With AI

With Intelligencia AI you can reduce the uncertainty of drug development with tools that deliver actionable insights and improve decision accuracy.

Evaluate Pipeline Options

Compare internal pipeline opportunities with the competitive landscape tapping AI to identify the best path forward.

Greater Visibility Into Approval Probability

Understand the likelihood of success by leveraging predictive analytics.

Focus on What Matters

Prioritize the most promising opportunities using robust data insights.
Schedule a Demo

“AI is very good at telling you A is better than B or vice versa. Even a small benefit from AI can be a good return on investment. If you just move the needle by a fraction of a percent of the probability of success, you’ve paid for your service 10 times, 30 times, 50 times, 100 times. The risk of not investing in AI is far greater than investing in it and learning.”

– VP, Head of Global Portfolio Management, Valuation & Analytics

Access Unbiased, AI-driven PTRS Assessments

Having an accurate and reliable AI-driven probability of  technical and regulatory success (PTRS) is vital for pharmaceutical companies when it comes to elevating decision-making and reducing risks.  

Improve Risk Assessments

Use predictive tools and data-driven insights to identify and address potential hurdles early.

Gain Strategic Insights

Leverage AI coupled with bespoke analysis to provide objective recommendations for portfolio strategies.

Maximize Return on Investment

Incremental improvements in PTRS can drive significant financial benefits.
SCHEDULE A DEMO

Reduce Drug Development Costs With AI​

Reducing costs without compromising innovation is essential in today’s pharmaceutical landscape. Intelligencia AI provides tailored AI and machine learning for drug development solutions to address this challenge.

Efficient Resource Allocation

Analyze comprehensive datasets and insights derived to pinpoint decisions that could create cost-saving opportunities.

Data-Driven Insights

Analyze comprehensive datasets and insights derived to pinpoint decisions that could create cost-saving opportunities.

Accelerate Decision Timelines

Streamline go/no-go decisions with actionable recommendations based on patented, accurate AI-driven PTRS assessments.
Schedule A Demo
Thank you for informing and enabling our portfolio strategy with a continuous stream of insights across emerging trends and salient competitive threats in our space.
VP of Portfolio Strategy, Biotech
Even a small benefit from AI can be a good return on investment. If you just move the needle by a fraction of a percent of the probability of success, you’ve paid for your service 10 times, 30 times, 50 times, 100 times. The risk of not investing in AI is far greater than investing in it and learning.
VP, Head of Global Portfolio Management, Valuation and Analytics
We did our competitive landscaping exercise and we are not aware of any other dataset that has been custom-built to address development risk.
Director, Global Pharmaceutical Company
Intelligencia AI has always taken a very thoughtful and rigorous process on everything you do and it is a great pleasure to work with you.
—Decision Analysis, Global Pharmaceutical Company
You are sitting on a goldmine.
Head of Statistics in Oncology